Bracco Imaging has launched a new effort at its Switzerland-based R&D center to evaluate gas-filled microbubbles, usually used for diagnostic imaging, as a delivery vehicle for personalized gene therapies to treat chronic dysfunctional diseases linked to lipid metabolism.
The research project is part of a deal that Bracco signed with startup SonoGene, which is developing platforms for the therapeutic delivery of genes and drugs using ultrasound-triggered microbubble delivery systems.
Get the full story at our sister site, Drug Delivery Business News.
The post Bracco Imaging explores using microbubbles to deliver personalized gene therapy appeared first on MassDevice.